ArticlePharmacoEconomics2024

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.

Aneeka Hafeez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.